Literature DB >> 18160961

The RIFLE criteria and mortality in acute kidney injury: A systematic review.

Z Ricci1, D Cruz, C Ronco.   

Abstract

In 2004, the Acute Dialysis Quality Initiative workgroup proposed a multilevel classification system for acute kidney injury (AKI) identified by the acronym RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease). Several studies have been published aiming to validate and apply it in clinical practice, verifying whether outcome progressively worsened with the severity of AKI. A literature search from August 2004 to June 2007 was conducted: 24 studies in which the RIFLE classification was used to define AKI were identified. In 13 studies, patient-level data on mortality were available for Risk, Injury, and Failure patients, as well as those without AKI (non-AKI). Death was reported at ICU discharge, hospital discharge, 28, 30, 60, and 90 days. The pooled estimate of relative risk (RR) for mortality for patients with R, I, or F levels compared with non-AKI patients were analyzed. Over 71 000 patients were included in the analysis of published reports. With respect to non-AKI, there appeared to be a stepwise increase in RR for death going from Risk (RR=2.40) to Injury (RR=4.15) to Failure (6.37, P<0.0001 for all). There was significant intertrial heterogeneity as expected with the varying patient populations studied. The RIFLE classification is a simple, readily available clinical tool to classify AKI in different populations. It seems to be a good outcome predictor, with a progressive increase in mortality with worsening RIFLE class. It also suggests that even mild degrees of kidney dysfunction may have a negative impact on outcome. Further refinement of RIFLE nomenclature and classification is ongoing.

Entities:  

Mesh:

Year:  2007        PMID: 18160961     DOI: 10.1038/sj.ki.5002743

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  247 in total

1.  Acute kidney injury: diagnosis and classification of AKI: AKIN or RIFLE?

Authors:  Sean M Bagshaw
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

2.  Use of blood urea nitrogen, creatinine, interleukin-6, granulocyte-macrophage colony stimulating factor in combination to predict the severity and outcome of abdominal sepsis in rats.

Authors:  Min Gao; Lingli Zhang; Ying Liu; Mingshi Yang; Nian Wang; Kangkai Wang; Danmin Ou; Meidong Liu; Guangwen Chen; Ke Liu; Xianzhong Xiao
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

Review 3.  Acute Renal Failure of Nosocomial Origin.

Authors:  Mark Dominik Alscher; Christiane Erley; Martin K Kuhlmann
Journal:  Dtsch Arztebl Int       Date:  2019-03-01       Impact factor: 5.594

Review 4.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

5.  Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research.

Authors:  Edward D Siew; Josh F Peterson; Svetlana K Eden; Karel G Moons; T Alp Ikizler; Michael E Matheny
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

6.  Comparison of kidney disease: improving global outcomes and acute kidney injury network criteria for assessing patients in intensive care units.

Authors:  Hibiki Shinjo; Waichi Sato; Enyu Imai; Tomoki Kosugi; Hiroki Hayashi; Kunihiro Nishimura; Kimitoshi Nishiwaki; Yukio Yuzawa; Seiichi Matsuo; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2013-11-27       Impact factor: 2.801

7.  Acute kidney injury is independently associated with mortality in very low birthweight infants: a matched case-control analysis.

Authors:  David J Askenazi; Russell Griffin; Gerald McGwin; Waldemar Carlo; Namasivayam Ambalavanan
Journal:  Pediatr Nephrol       Date:  2009-02-24       Impact factor: 3.714

Review 8.  Slit2-Robo signaling in inflammation and kidney injury.

Authors:  Swasti Chaturvedi; Lisa A Robinson
Journal:  Pediatr Nephrol       Date:  2014-04-29       Impact factor: 3.714

9.  Determining the incidence of drug-associated acute kidney injury in nursing home residents.

Authors:  Steven M Handler; Pui Wen Cheung; Colleen M Culley; Subashan Perera; Sandra L Kane-Gill; John A Kellum; Zachary A Marcum
Journal:  J Am Med Dir Assoc       Date:  2014-05-10       Impact factor: 4.669

10.  Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium.

Authors:  Moataz M Hassan; Zied Gaifer; Ibrahim S Al-Zakwani
Journal:  Int J Clin Pharm       Date:  2018-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.